Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic
- Conditions
- AnxietyDepressionPregnancy Related
- Interventions
- Other: Pandemic control measures
- Registration Number
- NCT04377412
- Lead Sponsor
- Żelazna Medical Centre, LLC
- Brief Summary
The article presents a protocol of a cross-sectional study of mental health of pregnant women in relation to the COVID 19 pandemic. The primary aim is to compare differences in anxiety and depression scores of pregnant women between countries affected by the COVID-19 pandemic. The secondary aim is to assess demographic, economic, and social aspects affecting maternal anxiety and depression scores among pregnant women worldwide in the time of the COVID-19 pandemic. Finally, investigators will be able to compare differences in perception of the different aspects of the COVID-19 pandemic (social distancing, restrictions related to delivery) between countries and according to the epidemic status (number of infected patients, number of reported deaths). The comparisons will also be done according to COVID-19 status of the participants.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 8500
- declaration of being pregnant
- being able to complete the survey in the available languages
- answer the screening questions
- provide informed consent for participation
- not providing online informed consent for participation
- if the participant does not click on the submit button at the end of the survey
- not answer all the GAD-7 and PHQ-9 scale questions
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description United States Pandemic control measures - Sweden Pandemic control measures - Taiwan Pandemic control measures - Albania Pandemic control measures - Lebanon Pandemic control measures - Norway Pandemic control measures - Poland Pandemic control measures - Russia Pandemic control measures - Czech Republic Pandemic control measures - France Pandemic control measures - Germany Pandemic control measures - Spain Pandemic control measures - Ukraine Pandemic control measures - Australia Pandemic control measures - Hong Kong Pandemic control measures - Italy Pandemic control measures - Israel Pandemic control measures -
- Primary Outcome Measures
Name Time Method Anxiety 4 months Anxiety measured by General Anxiety Disorder-7 (GAD-7) scale. Scoring:5-9 mild; 10-14 moderate; \>15 severe. Minimum 0, maximum 21 points
Depression 4 months Depression measured by Patient Health Questionnaire-9 (PHQ-9) scale. Scoring: 5-9 mild;10-14 moderate; 15-19 moderately severe; \>20 severe. Minimum 0 maximum 27 points
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (17)
Pomeranian Medical University
🇵🇱Szczecin, Poland
University of Brescia
🇮🇹Brescia, Italy
The Chinese University of Hong Kong
🇭🇰Hong Kong, Hong Kong
Meir Medical Center
🇮🇱Kafr Saba, Israel
Charité - University Medicine Berlin
🇩🇪Berlin, Germany
Royal Prince Alfred Hospital
🇦🇺Sydney, Australia
Charles University
🇨🇿Prague, Czechia
Université de Paris
🇫🇷Paris, France
Wayne State University
🇺🇸Detroit, Michigan, United States
11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal "iMaterna"
🇪🇸Madrid, Spain
Centre of Postgraduate Medical Education
🇵🇱Warsaw, Poland
Taiji Clinic
🇨🇳Taipei, Taiwan
University of Medicine Tirana
🇦🇱Tirana, Albania
The Arctic University of Norway
🇳🇴Tromsø, Norway
Karolinska Institutet
🇸🇪Stockholm, Sweden
American University of Beirut
🇱🇧Beirut, Lebanon
Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz
🇵🇱Bydgoszcz, Poland